Southern California TMS Center

What Southern California TMS Center does

Southern California TMS Center is a privately held, physician-led outpatient mental health practice founded in 2009 by Dr. Todd Hutton in Pasadena, California, specializing in transcranial magnetic stimulation (TMS) for patients with treatment-resistant major depressive disorder. The practice operates 13 clinic locations across five Southern California counties (Los Angeles, Orange, San Bernardino, Riverside, and Ventura) and has administered more than 200,000 TMS treatments over its lifetime, positioning itself as one of the earliest providers following the FDA's October 2008 clearance and self-described as the nation's leading TMS provider. Its clinical leadership includes Dr. Hutton as President of the Clinical TMS Society and Associate Clinical Professor at USC Keck School of Medicine, alongside Dr. Shameer Debnath as a second dual-boarded psychiatrist.

The core technology is the NeuroStar TMS System, a non-invasive device that delivers MRI-strength magnetic pulses to underactive brain regions implicated in depression, triggering neuronal firing and Brain-Derived Neurotrophic Factor (BDNF) release. Treatment courses run 5 days per week for 4-6 weeks, with each session lasting approximately 30 minutes and priced at $300-$500; the practice has since added Spravato (esketamine) nasal spray therapy at $500-$2,300 per session as a second modality for severe, treatment-resistant cases. The company is in-network with major commercial carriers including Anthem, Kaiser Permanente, Blue California, Magellan, Aetna, United Healthcare, and Cigna, and additionally serves VA patients, with insurance verification and prior authorization handled in-house.

The go-to-market combines physician referral partnerships (psychiatrists, primary care, therapists, and quarterly seminars in alliance with NAMI) with direct-to-patient demand generation through SEO, paid search (Google Ads), social channels including TikTok, and a Typeform self-assessment funnel. Outcomes research has been published in the Brain Stimulation Journal, and the practice has appeared on Inside SoCal Sunday Morning, The Daily Show, KTLA, and American News Report, reinforcing a brand-led acquisition motion layered on top of the referral base.

Name

Southern California TMS Center

Legal name

Southern California TMS Center, Inc

Website

https://socaltms.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Southern California TMS Center is a Pasadena-based, physician-led outpatient practice operating 13 clinics across Southern California that delivers FDA-cleared transcranial magnetic stimulation and Spravato therapy primarily to patients with treatment-resistant major depression, reimbursed through major commercial insurance networks and physician referrals.

Ownership category

akta.pro rank

Headquarters

HQ city

Pasadena

HQ country

United States

HQ region

North America

Offices13 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Insurance-Reimbursed TMS Treatments: Fee-for-service medical treatments reimbursed through health insurance. Covered by most major commercial carriers including Anthem, Kaiser, Blue California, Magellan, Aetna, United Healthcare, Cigna, and others. Prior authorization typically required.
2. Out-of-Pocket Patient Payments: Self-pay patients covering deductibles, co-pays, or coinsurance. Flexible payment plans and financial assistance options available for those without coverage.
3. Spravato (Esketamine) Nasal Spray Therapy: Additional treatment service for severe depression, priced between $500 to $2,300 per session depending on prescribed dose and frequency.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Southern California TMS Center provides outpatient Transcranial Magnetic Stimulation (TMS) therapy, an FDA-cleared non-invasive treatment using MRI-strength magnetic pulses to stimulate underactive brain regions in patients with major depression. The center also administers Spravato (esketamine) nasal spray therapy for treatment-resistant depression across 13 Southern California clinic locations, delivering treatments over a typical 4-6 week protocol without anesthesia or systemic medication.

Product overview

Southern California TMS Center operates as a healthcare provider offering two main treatment modalities: Transcranial Magnetic Stimulation (TMS) therapy and Spravato (Esketamine) nasal spray therapy. TMS is the primary offering—a non-invasive, non-systemic procedure using MRI-strength magnetic pulses to stimulate underactive brain regions in depression patients. Spravato is an adjunct/esketamine-based nasal spray treatment for severe, treatment-resistant depression cases. Both treatments are outpatient procedures performed at the company's multiple Southern California clinic locations without requiring anesthesia.

Differentiator

Problem solved

Functional benefit

Products and services

• Transcranial Magnetic Stimulation (TMS) Therapy FDA-cleared non-invasive outpatient treatment using MRI-strength magnetic pulses to stimulate underactive areas of the brain associated with depression. Administered in-office without anesthesia, lasting approximately 30 minutes per session, typically given 5 days a week for 4-6 weeks. Targets patients with treatment-resistant major depression who have failed first-line antidepressant medications.
• Spravato (Esketamine) Nasal Spray Therapy

Quantifiable outcome

• 50-60% meaningful reaction rate within first session for treatment-resistant patients
• +3 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core, major and minor.

• NeuroStar (Advanced NeuroHealth)coreTechnology or IntegrationNeuroStar is the manufacturer of the TMS equipment used at SoCal TMS centers. The NeuroStar TMS System is FDA-approved for treatment of major depression and is the core technology platform utilized across all 13 SoCal TMS clinic locations.
• Kaiser PermanentemajorChannel Partner/ Reseller/ DistributorKaiser Permanente is an in-network insurance provider for TMS treatments at SoCal TMS. The company has treated Kaiser patients and has a dedicated team for Kaiser insurance verification and authorization processes.
• Clinical TMS SocietymajorStrategic or Co-development PartnerInternational association of TMS providers from around the globe. Dr. Todd Hutton serves as President of the Clinical TMS Society, providing leadership and contributing to the advancement of TMS therapy standards and practices.
• NAMI (National Alliance on Mental Illness)minorStrategic or Co-development PartnerAlliance with NAMI for mental health advocacy and outreach. Part of efforts to stay connected with patients and speak for those not always able to speak for themselves regarding mental health issues.
• Veterans Affairs (VA)minorChannel Partner/ Reseller/ DistributorTreatment provided for VA patients in addition to commercial insurance. Represents partnership with government healthcare system for serving veterans with depression.
• Huntington Memorial HospitalminorStrategic or Co-development PartnerDr. Todd Hutton is on staff at Huntington Memorial Hospital in Pasadena, CA, providing hospital-based psychiatric services in addition to outpatient TMS treatment.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Greenbrook TMS: Largest publicly-traded TMS clinic operator in North America, running hundreds of centers that deliver NeuroStar-based TMS for treatment-resistant depression. SoCal TMS competes for the same patient pool, payer contracts, and referring physicians using an identical modality.
• Smart TMS: Multi-location TMS provider operating clinics in the UK and US for depression and related psychiatric conditions. Closely aligned treatment protocols, modality, and patient concentration in treatment-resistant depression.
• MindPath Health: Psychiatry and behavioral health group offering TMS alongside medication management and therapy across multiple clinic locations. Competes for similar patient demographics and integrated-care referrals in the Southern California market.
• Achieve TMS: Regional TMS clinic chain offering transcranial magnetic stimulation and related psychiatric services for treatment-resistant depression and anxiety. Directly comparable outpatient model, payer mix, and patient segments to Southern California TMS Center.

Others

• Neuronetics: Public manufacturer of the NeuroStar TMS System that SoCal TMS uses across all 13 clinics, and an increasingly active direct clinic operator through subsidiary NeuroStar Centers. Provides both the technology stack and an emerging vertically-integrated competitor model.
• Cleveland Clinic: Major academic medical system with an established TMS program for treatment-resistant depression and related psychiatric indications. Represents the hospital-based delivery counterpart to SoCal TMS's standalone-clinic model.

Broad incumbents

• McLean Hospital: Harvard-affiliated psychiatric hospital with an outpatient TMS program for treatment-resistant depression. Represents the academic-medical-center side of the same patient segment SoCal TMS targets at commercial-clinic scale.
• Amen Clinics: Established multi-clinic psychiatric and brain-health network offering SPECT imaging, TMS, and related services. Operates in overlapping treatment-resistant depression and behavioral health patient pools, with a broader service portfolio than SoCal TMS.

Emerging players

• BetterHelp: Large online therapy platform increasingly extending into psychiatric and treatment-resistant depression services. An emerging delivery model for the same patient base that SoCal TMS serves in-person.

Regional players

• Cedars-Sinai Medical Center: Los Angeles-based academic medical system offering TMS as part of its broader behavioral health and depression services. A direct geographic peer in SoCal that competes for in-network referrals and tertiary depression cases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/socaltms
• Facebookfacebook.com/socaltmscenter
• LinkedInlinkedin.com/company/southern-california-tms-center
• Instagraminstagram.com/socaltms
• TikToktiktok.com/@socaltms

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Southern California TMS Center